Characteristics of the study population with type 2 diabetes
| Variable | |
| n | 119 |
| Anthropometric data | |
| Age, years | 69.7±9.9 (38.0–92.0) |
| Males, n (%) | 90 (76) |
| Weight, kg | 89.3±17.0 (60.0–135.0) |
| Height, cm | 172.0±9.2 (149.0–197.0) |
| Body mass index, kg/m2 | 30.1±4.7 (21.0–42.6) |
| Clinical data, n (%) | |
| Dyslipidemia | 71 (60) |
| Coronary heart disease | 81 (68) |
| Cerebrovascular disease | 8 (7) |
| Hypertension | 117 (98) |
| Chronic kidney disease | 21 (18), 1=14 (66.6), 2=1 (4.8), 3=5 (23.8), |
| Stage 1–5 | 4=0 (0.0), 5=1 (4.8) |
| Patients undergoing PCI | 71 (60%) |
| Smoking | 24 (29) |
| Heart rate, bpm | 70.6±13.6 (44.0–136.0) |
| Invasive aortic blood pressure, mmHg | |
| Systolic | 137.9±23.2 (68.6–191.6) |
| Diastolic | 68.0±10.4 (37.2–98.7) |
| MAP | 96.0±13.2 (49.8–133.1) |
| Non-invasive oscillometric brachial blood pressure, mmHg | |
| Systolic | 146.1±23.0 (74.0–211.0) |
| Diastolic | 82.1±10.5 (53.0–113.0) |
| MAP | 104.1±15.1 (58.0–139.0) |
All values, except percentages, are presented as mean±SD (min–max).
bpm, beats per minute; MAP, mean arterial pressure; PCI, percutaneous coronary intervention.